FLVCR2 and cancer: A growing number of studies show that about 10–15% of newly synthesized proteins interact with CCT, including numerous essential structural and regulatory proteins such as the cell cycle regulator CDC20, the cancer-related VHL tumor suppressor, and WD40-repeat proteins [7,8,9].